Reporting owner · CIK 0001643746

Kim Lorence H.

Visual SEC Form 4 history across 2 companies, 8 transactions and 2 filings.

DIRRevolution Medicines, Inc.
Open-market mix
Latest filingSep 02, 2026, 08:30 PM
Filings2Form 4 records
Buying$00 purchases
Selling$11.4M7 sales
Net value−$11.4MBuys minus sells
Companies21 securities
Most recentAug 31, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-10Mar 257Aug 26

Net value flow

Buys minus sells

Mar 25
$0
Aug 26
−$11.4M

Transaction texture

Ownership and ticket size

Average P/S size$1.6M
Median P/S size$1.3M
Direct1
Indirect7
Aug 31, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Direct Ownershipfiling-context1

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Revolution Medicines, Inc. on Aug 31, 2026 valued at $128,846.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Revolution Medicines, Inc. on Aug 31, 2026 valued at $128,846.

Review SEC filing

Associated companies

Visual map of known reporting history

RVMDRevolution Medicines, Inc.7 transactions · latest Sep 02, 2026, 08:30 PMCORCencora, Inc.1 transactions · latest Mar 10, 2025, 10:07 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
RVMDKim Lorence H.
DIR
sale10b5-1625-$12.8MS
Repeat Seller 10b5-1 Detected
0.0%09/0208/31
RVMDKim Lorence H.
DIR
sale10b5-12.12k-$43.6MS
Repeat Seller 10b5-1 Detected
0.0%09/0208/31
RVMDKim Lorence H.
DIR
sale10b5-17.27k-$148MS
Large Holdings Reduction Large Sale Repeat Seller+1
0.0%09/0208/31
RVMDKim Lorence H.
DIR
sale10b5-126.1k-$532MS
Large Holdings Reduction Large Sale Repeat Seller+1
0.0%09/0208/31
RVMDKim Lorence H.
DIR
sale10b5-112.9k-$261MS
Large Sale Repeat Seller 10b5-1 Detected
0.0%09/0208/31
RVMDKim Lorence H.
DIR
sale10b5-16.59k-$132MS
Large Sale Repeat Seller 10b5-1 Detected
0.0%09/0208/31
RVMDKim Lorence H.
DIR
sale10b5-1300-$6.01MS
10b5-1 Detected
0.0%09/0208/31
CORKim Lorence H.
DIR
grant789—A
Direct Ownership
—03/10/202503/06/2025

Kim Lorence H. Insider Activity FAQ

SEC Form 4 context

Who is Kim Lorence H.?

Kim Lorence H. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001643746.

Which companies has Kim Lorence H. reported transactions for?

Revolution Medicines, Inc., Cencora, Inc.

When was Kim Lorence H.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Kim Lorence H.'s latest insider sale?

sale at Revolution Medicines, Inc. on Aug 31, 2026 valued at $128,846.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.